US Stock MarketDetailed Quotes

CDTX Cidara Therapeutics

Watchlist

20.2100
+0.0100+0.05%

Close Nov 29 13:00 ET

20.2100
0.00000.00%

Post 17:01 ET

221.08MMarket Cap-872P/E (TTM)

Cidara Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Total revenue

-94.07%302K

-67.58%8.46M

-0.84%63.91M

317.94%43.38M

-77.38%9.22M

-18.11%5.09M

267.24%26.11M

30.01%64.45M

43.65%10.38M

Operating revenue

--0

-94.07%302K

-67.58%8.46M

-0.84%63.91M

317.94%43.38M

-77.38%9.22M

-18.11%5.09M

267.24%26.11M

30.01%64.45M

43.65%10.38M

Cost of revenue

1.56M

1.52M

Gross profit

-73.57%6.9M

-3.21%62.38M

26.11M

64.45M

10.38M

Operating expense

27.10%17.39M

-3.67%11.4M

-24.59%17.59M

-11.32%86.87M

74.91%47.98M

-47.00%13.69M

-38.76%11.84M

-8.06%23.33M

6.67%97.95M

14.32%27.43M

Selling and administrative expenses

50.50%4.97M

49.20%4.75M

34.57%6M

-10.77%18.33M

49.42%8.2M

-42.92%3.3M

-21.92%3.18M

-14.35%4.46M

9.64%20.55M

10.16%5.49M

-General and administrative expense

----

49.20%4.75M

34.57%6M

-10.77%18.33M

----

-21.92%3.18M

-14.35%4.46M

9.64%20.55M

10.16%5.49M

Research and development costs

19.67%12.43M

-23.10%6.66M

-38.56%11.59M

-11.46%68.53M

81.28%39.78M

-48.18%10.39M

-43.25%8.66M

-6.43%18.87M

5.91%77.41M

15.41%21.94M

Operating profit

-289.30%-17.39M

-64.51%-11.1M

-484.43%-10.69M

26.92%-24.48M

64.09%-6.12M

-129.94%-4.47M

48.54%-6.75M

115.23%2.78M

20.71%-33.5M

-1.68%-17.05M

Net non-operating interest income expense

203.26%1.86M

184.75%1.77M

57.33%365K

944.50%2M

225.31%527K

1,014.55%613K

10,483.33%623K

1,260.00%232K

190.09%191K

590.91%162K

Non-operating interest income

203.26%1.86M

----

57.33%365K

944.50%2M

225.31%527K

1,014.55%613K

----

--232K

--191K

--162K

Total other finance cost

----

-184.75%-1.77M

----

-10,483.33%-623K

----

Other net income (expense)

-84.88M

Special income (charges)

----

---84.88M

----

--0

----

-Less:Other special charges

----

--84.88M

----

Income before tax

-302.98%-15.54M

-1,438.12%-94.21M

-442.71%-10.33M

32.49%-22.49M

66.86%-5.6M

-125.74%-3.86M

53.31%-6.13M

116.48%3.01M

21.56%-33.31M

-0.52%-16.89M

Income tax

62.87%443K

59.93%435K

-32K

40K

272K

Net income

-75.52%-15.99M

-569.47%-91.21M

-442.71%-10.33M

31.72%-22.93M

81.28%-3.21M

-160.80%-9.11M

-3.85%-13.62M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

Net income continuous Operations

-306.36%-15.54M

-1,428.14%-94.21M

-442.71%-10.33M

31.72%-22.93M

64.85%-6.03M

-125.52%-3.82M

53.01%-6.17M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

Net income discontinuous operations

91.48%-450K

140.23%3M

----

---5.28M

---7.46M

----

Minority interest income

Net income attributable to the parent company

-75.52%-15.99M

-569.47%-91.21M

-442.71%-10.33M

31.72%-22.93M

81.28%-3.21M

-160.80%-9.11M

-3.85%-13.62M

116.48%3.01M

20.92%-33.58M

-2.14%-17.16M

Preferred stock dividends

Other preferred stock dividends

636K

Net income attributable to common stockholders

-75.52%-15.99M

-569.47%-91.21M

-534.41%-10.33M

31.72%-22.93M

81.28%-3.21M

-176.55%-9.11M

-3.85%-13.62M

113.00%2.38M

20.92%-33.58M

-2.14%-17.16M

Basic earnings per share

-21.29%-2.45

-561.92%-19.99

-480.00%-2.28

45.83%-5.2

83.16%-0.64

-159.41%-2.02

20.53%-3.02

111.11%0.6

40.74%-9.6

26.92%-3.8

Diluted earnings per share

-21.29%-2.45

-561.92%-19.99

-480.00%-2.28

45.83%-5.2

83.16%-0.64

-159.41%-2.02

20.53%-3.02

111.11%0.6

40.74%-9.6

26.92%-3.8

Dividend per share

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Total revenue	0	-94.07%302K	-67.58%8.46M	-0.84%63.91M	317.94%43.38M	-77.38%9.22M	-18.11%5.09M	267.24%26.11M	30.01%64.45M	43.65%10.38M
Operating revenue	--0	-94.07%302K	-67.58%8.46M	-0.84%63.91M	317.94%43.38M	-77.38%9.22M	-18.11%5.09M	267.24%26.11M	30.01%64.45M	43.65%10.38M
Cost of revenue			1.56M	1.52M				0	0	0
Gross profit			-73.57%6.9M	-3.21%62.38M				26.11M	64.45M	10.38M
Operating expense	27.10%17.39M	-3.67%11.4M	-24.59%17.59M	-11.32%86.87M	74.91%47.98M	-47.00%13.69M	-38.76%11.84M	-8.06%23.33M	6.67%97.95M	14.32%27.43M
Selling and administrative expenses	50.50%4.97M	49.20%4.75M	34.57%6M	-10.77%18.33M	49.42%8.2M	-42.92%3.3M	-21.92%3.18M	-14.35%4.46M	9.64%20.55M	10.16%5.49M
-General and administrative expense	----	49.20%4.75M	34.57%6M	-10.77%18.33M	----	----	-21.92%3.18M	-14.35%4.46M	9.64%20.55M	10.16%5.49M
Research and development costs	19.67%12.43M	-23.10%6.66M	-38.56%11.59M	-11.46%68.53M	81.28%39.78M	-48.18%10.39M	-43.25%8.66M	-6.43%18.87M	5.91%77.41M	15.41%21.94M
Operating profit	-289.30%-17.39M	-64.51%-11.1M	-484.43%-10.69M	26.92%-24.48M	64.09%-6.12M	-129.94%-4.47M	48.54%-6.75M	115.23%2.78M	20.71%-33.5M	-1.68%-17.05M
Net non-operating interest income expense	203.26%1.86M	184.75%1.77M	57.33%365K	944.50%2M	225.31%527K	1,014.55%613K	10,483.33%623K	1,260.00%232K	190.09%191K	590.91%162K
Non-operating interest income	203.26%1.86M	----	57.33%365K	944.50%2M	225.31%527K	1,014.55%613K	----	--232K	--191K	--162K
Total other finance cost	----	-184.75%-1.77M	----	----	----	----	-10,483.33%-623K	----	----	----
Other net income (expense)		-84.88M
Special income (charges)	----	---84.88M	----	----	----	----	--0	----	----	----
-Less:Other special charges	----	--84.88M	----	----	----	----	----	----	----	----
Income before tax	-302.98%-15.54M	-1,438.12%-94.21M	-442.71%-10.33M	32.49%-22.49M	66.86%-5.6M	-125.74%-3.86M	53.31%-6.13M	116.48%3.01M	21.56%-33.31M	-0.52%-16.89M
Income tax	0	0		62.87%443K	59.93%435K	-32K	40K		272K	272K
Net income	-75.52%-15.99M	-569.47%-91.21M	-442.71%-10.33M	31.72%-22.93M	81.28%-3.21M	-160.80%-9.11M	-3.85%-13.62M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M
Net income continuous Operations	-306.36%-15.54M	-1,428.14%-94.21M	-442.71%-10.33M	31.72%-22.93M	64.85%-6.03M	-125.52%-3.82M	53.01%-6.17M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M
Net income discontinuous operations	91.48%-450K	140.23%3M	----	----	----	---5.28M	---7.46M	----	----	----
Minority interest income
Net income attributable to the parent company	-75.52%-15.99M	-569.47%-91.21M	-442.71%-10.33M	31.72%-22.93M	81.28%-3.21M	-160.80%-9.11M	-3.85%-13.62M	116.48%3.01M	20.92%-33.58M	-2.14%-17.16M
Preferred stock dividends
Other preferred stock dividends			0					636K
Net income attributable to common stockholders	-75.52%-15.99M	-569.47%-91.21M	-534.41%-10.33M	31.72%-22.93M	81.28%-3.21M	-176.55%-9.11M	-3.85%-13.62M	113.00%2.38M	20.92%-33.58M	-2.14%-17.16M
Basic earnings per share	-21.29%-2.45	-561.92%-19.99	-480.00%-2.28	45.83%-5.2	83.16%-0.64	-159.41%-2.02	20.53%-3.02	111.11%0.6	40.74%-9.6	26.92%-3.8
Diluted earnings per share	-21.29%-2.45	-561.92%-19.99	-480.00%-2.28	45.83%-5.2	83.16%-0.64	-159.41%-2.02	20.53%-3.02	111.11%0.6	40.74%-9.6	26.92%-3.8
Dividend per share
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion with Explanatory Notes	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall

No Data